Differential expression of lysine acetylation proteins in gastric cancer treated with a new antitumor agent bioactive peptide chelate selenium.

Xu, Yanan; Wen, Jianxun; Han, Wenyan; Yan, Jin; Jia, Wei; Su, Xiulan

Xu, Yanan; Wen, Jianxun; Han, Wenyan; Yan, Jin; Jia, Wei; Su, Xiulan.

Affiliation

Xu Y; Clinical Medical Research Center, Inner Mongolia Bioactive Peptide Engineering Laboratory, The Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.
Wen J; College of Basic Medicine, Inner Mongolia Medical University, Hohhot, China.
Han W; Clinical Laboratory, The Second Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.
Yan J; Clinical Medical Research Center, Inner Mongolia Bioactive Peptide Engineering Laboratory, The Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.
Jia W; Clinical Medical Research Center, Inner Mongolia Bioactive Peptide Engineering Laboratory, The Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.
Su X; Clinical Medical Research Center, Inner Mongolia Bioactive Peptide Engineering Laboratory, The Affiliated Hospital, Inner Mongolia Medical University, Hohhot, China.

PeerJ ; 11: e14384, 2023.

Article de En | MEDLINE | ID: mdl-36684675

Sujet(s)
Mots clés

Acetylation; Anticancer bioactive peptides; Gastric cancer; Selenium

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Sélénium / Tumeurs de l'estomac / Antinéoplasiques Type d'étude: Guideline / Prognostic_studies Limites: Humans Langue: En Journal: PeerJ Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google